{
    "nct_id": "NCT03837496",
    "official_title": "Symptom-Targeted Randomized Intervention for Distress and Adherence to Adjuvant Endocrine Therapy (STRIDE) Among Breast Cancer Survivors: A Pilot Feasibility Trial",
    "inclusion_criteria": "* Female\n* Age 21 or older\n* Diagnosis of early-stage (Stage 0-IIIb), hormone receptor + breast cancer\n* Within 1 week-36 months of starting adjuvant endocrine therapy\n* Ability to read and respond in English\n* Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2\n* Currently taking adjuvant endocrine therapy (i.e. if took recent break, has taken within the past 2 weeks)\n* Completed primary treatment (i.e., chemotherapy, surgery, and/or radiation) for early-stage breast cancer\n* Indicates a score ≥4 on one of the three NCCN adapted distress thermometer study screening questions\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 21 Months",
    "exclusion_criteria": "* Uncontrolled psychosis, active suicidal ideation, or psychiatric hospitalization within the past year\n* Cognitive impairment that prohibits participation in the study\n* Enrollment in a different clinical trial for breast cancer\n* Current participation in formal group psychotherapy or other psychosocial intervention trial\n* Undergoing primary treatment for other cancer (i.e., advanced stage cancer)",
    "miscellaneous_criteria": ""
}